RỐI LOẠN LO ÂU, STRESS Ở BỆNH NHÂN COVID-19 NGÀY ĐẦU NHẬP VIỆN TẠI BỆNH VIỆN QUÂN DÂN Y MIỀN ĐÔNG

Mai Trần Thị Quỳnh; Hoàn Bùi Thị; Thúy Thái Thị; Việt Trương Hoàng; Toàn Nguyễn Cảnh; Công Nguyễn Đức

doi:10.59354/ydth175.2023.218

Keywords:

Anxiety disorder, stress disorder, COVID-19, DASS 21

Abstract

Introduction: Previous studies reported that there were anxiety and stress disorders in patients infected with SARS-CoV-2. However, those disorders in COVID-19 patients were not well studied in Vietnam.

Materials-Methods: Cross-sectional study implemented on 298 patients who were diagnosed with SARS-CoV-2 infection by RT-PCR. They were hospitalized for isolation and treatment from July 2021 to August 2021. Level of anxiety and stress on the first day of hospital admission was followed by The Depression Anxiety Stress Scales (DASS 21).

Results: The prevalence of anxiety and stress in COVID-19 patients on the first day of hospital admission was 83.2% and 81.2%, respectively. The rate of anxiety was significantly higher (p < 0.05) in the group ≥ 40 years compared with < 40 (95.6% and 79.6%), with symptomatic compared with none (85.2% and 72.9%), with underlying disease versus no (88.9% and 82.7%), moderate/severe versus mild COVID-19 (98.5% and 77.3%, respectively). The rate of moderate or severe anxiety was significantly greater in the group ≥ 40 years old, BMI ≥ 25 kg/m2, with underlying disease, moderate/ severe COVID-19 (72.1%, 76.2%, 77.8%, and 90.5%, respectively) compared with the other group (56.5%, 57.4%, 58.3%, and 45.8%, respectively). The prevalence of stress was significantly superior in the group ≥ 40 years (92.6% vs 77.8%), BMI ≥ 25 kg/m2 (95.2% vs 78.9%), symptomatic (83.2% vs 70.8%), moderate/severe COVID-19 (96.8% vs 73.9%, respectively). The rate of moderate or severe stress was higher in the group with underlying disease, moderate/severe COVID-19 (63.0%, 84.2%, respectively) compared to the other group (40.2%, 22.7%).

Conclusions: The rates of anxiety and stress in COVID-19 patients on the first day of hospital admission were high. The rate of anxiety or stress was higher in the group of patients aged ≥ 40, BMI ≥ 25 kg/m2, with underlying disease, symptomatic compared with the group with age < 40, BMI < 25 kg/m2, without underlying disease, no symptoms. The severity of COVID-19 increased both the prevalence and severity of both anxiety and stress.

References

Quyết định 3416/QĐ-BYT ngày 14/07/2021 của Bộ Y tế về việc Ban hành hướng dẫn chẩn đoán và điều trị COVID-19 do chủng vi rút Corona mới (SARS-CoV-2).

Zandifar A., Badrfam R., Yazdani S., et al. (2020). Prevalence and severity of depression, anxiety, stress and perceived stress in hospitalized patients with COVID-19. J Diabetes Metab Disord, 19(2), 1431–1438.

Nabi S.G., Rashid M.U., Sagar S.K., et al. (2022). Psychological impact of COVID-19 pandemic: A cross-sectional study of hospitalized COVID-19 patients in an urban setting, Bangladesh. Heliyon, 8(3), e09110.

Duan L. and Zhu G. (2020). Psychological interventions for people affected by the COVID-19 epidemic. Lancet Psychiatry, 7(4), 300–302.

Zheng W. (2020). Mental health and a novel coronavirus (2019-nCoV) in China. J Affect Disord, 269, 201–202.

Moseholm E., Midtgaard J., Bollerup S., et al. (2022). Psychological Distress among Hospitalized COVID-19 Patients in Denmark during the First 12 Months of the Pandemic. Int J Environ Res Public Health, 19(16), 10097.

Liu K., Chen Y., Wu D., et al. (2020). Effects of progressive muscle relaxation on anxiety and sleep quality in patients with COVID-19. Complement Ther Clin Pract, 39, 101132.